301126.SZ
Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd.
SZSE · F 批发零售 · CN
CNY 10.00
−1.67%Year over year
Reported trailing growth
- Revenue
- -0.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +27.7%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +16.0%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -55.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026